1
Clinical Trials associated with Glycolic acid tetrasubstituted piceatannolAn Open-label Study of the Safety and Pharmacokinetics of the Glycolic Acid Tetrasubstituted Piceatannol (TGKP, "Study Drug") With a Single Intravenous Administration With Participation of Healthy Volunteers: 3 Arms With Dose Escalation
The purpose of the trial is to study the tolerability, safety and pharmacokinetics of the study drug with participation of healthy volunteers after single intravenous administration with dose escalation (0.03 mg/kg, 0.06 mg/kg and 0.12 mg/kg).
Before administration the study drug will be dosed and diluted in 200 ml of isotonic solution of 0.9% sodium chloride, and then will be administered once intravenously via infusion.
During the entire follow-up period, the effect of the study drug on vital signs, instrumental and laboratory data, the development, severity and association of adverse events with the study drug will be monitored, investigated and studied.
100 Clinical Results associated with Glycolic acid tetrasubstituted piceatannol
100 Translational Medicine associated with Glycolic acid tetrasubstituted piceatannol
100 Patents (Medical) associated with Glycolic acid tetrasubstituted piceatannol
100 Deals associated with Glycolic acid tetrasubstituted piceatannol